Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Tumor Microenvironment. Found 11 abstracts

Greten FR, Grivennikov SI. Inflammation and Cancer: Triggers, Mechanisms, and Consequences. Immunity. 2019 Jul 16;51(1):27-41.   PMCID: PMC6831096
Aras S, Zaidi MR. TAMeless traitors: macrophages in cancer progression and metastasis. Br J Cancer. 2017 Oct 24;117(11):1583-91.   PMCID: PMC5729447
Dmitrieva O, Grivennikov SI. Microbiota and cancer: a complex equation with a lot of exciting unknowns. Seminars in immunology. 2017 Aug;32:1-2.   PMCID: Editorial
Liu Y, Yuelling LW, Wang Y, Du F, Gordon RE, O'Brien J, Ng JM, Robins S, Lee EH, Liu H, Curran T, Yang ZJ. Astrocytes promote medulloblastoma progression through hedgehog secretion. Cancer Res. 2017 Dec;77(23):6692-703.   PMCID: PMC5759326
Ribas A, Dummer R, Puzanov I, VanderWalde A, Andtbacka RH, Michielin O, Olszanski AJ, Malvehy J, Cebon J, Fernandez E, Kirkwood JM, Gajewski TF, Chen L, Gorski KS, Anderson AA, Diede SJ, Lassman ME, Gansert J, Hodi FS, Long GV. Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy. Cell. 2017 Sep 07;170(6):1109-1119e10.
Sato T, Issa JJ, Kropf P. DNA Hypomethylating Drugs in Cancer Therapy. Cold Spring Harbor perspectives in medicine. 2017 May;7(5).   PMCID: PMC5411681
Podszywalow-Bartnicka P, Cmoch A, Wolczyk M, Bugajski L, Tkaczyk M, Dadlez M, Nieborowska-Skorska M, Koromilas AE, Skorski T, Piwocka K. Increased phosphorylation of eIF2alpha in chronic myeloid leukemia cells stimulates secretion of matrix modifying enzymes. Oncotarget. 2016 Nov 29;7(48):79706-21.   PMCID: PMC5346746
Kwon Y, Smith BD, Zhou Y, Kaufman MD, Godwin AK. Effective inhibition of c-MET-mediated signaling, growth and migration of ovarian cancer cells is influenced by the ovarian tissue microenvironment. Oncogene. 2015 Jan;34(2):144-53.   PMCID: PMC4067476
Zhang I, Zaorsky NG, Palmer JD, Mehra R, Lu B. Targeting brain metastases in ALK-rearranged non-small-cell lung cancer. Lancet Oncol. 2015 Oct;16(13):e510-21.
Hutmacher DW, Cukierman E. Engineering of tumor microenvironments. Adv Drug Deliv Rev. 2014 Dec 15;79-80:1-2.
Obeid E, Nanda R, Fu YX, Olopade OI. The role of tumor-associated macrophages in breast cancer progression (review). Int J Oncol. 2013 Jul;43(1):5-12.   PMCID: PMC3742164
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Tumor Microenvironment

Tumor Microenvironment metabolism Neoplasms pathology immunology physiology genetics drug effects antagonists & inhibitors secretion drug therapy enzymology Carcinogenesis Extracellular Matrix Signal Transduction Neoplasm Invasiveness Fibroblasts Homeostasis therapeutic use Mice Cell Proliferation Cell Movement Macrophages Neoplasm Metastasis Female Inflammation Pathologic Neovascularization Disease Progression Microbiota Non-Small-Cell Lung Carcinoma Decitabine Clinical Trials as Topic Adjuvant Radiotherapy metastasis pharmacology Patched-1 Receptor Tumor Biomarkers oncolytic immunotherapy Aminopyridines Anilides Stromal Cells mechanisms Tumor Cell Line Cathepsins Nude Mice Monoclonal Antibodies-Humanized Medulloblastoma Transgenic Mice Cerebellar Neoplasms DNA Demethylation therapy cell plasticity microbiology etiology cell invasion analogs & derivatives biosynthesis Hepatocyte Growth Factor Hedgehog Proteins Cultured Cells oncolytic viruses interferon gamma Combined Modality Therapy anti-PD-1 Phosphorylation Brain Neoplasms Nestin Neoplastic Gene Expression Regulation proteases Oncolytic Virotherapy Chronic Disease Blood-Brain Barrier adverse effects Eukaryotic Initiation Factor-2 Astrocytes Paracrine Communication Random Allocation Bone Marrow Cells cytotixic Antineoplastic Antimetabolites Cml Proto-Oncogene Proteins c-met pembrolizumab Smoothened Receptor eIF2alpha Infections Neoplasm Drug Resistance Xenograft Model Antitumor Assays talimogene laherparepvec Immune Tolerance Antineoplastic Agents Phenotype Wound Healing cancer Ovarian Neoplasms T-Lymphocytes Protein Kinase Inhibitors tumor microenvironment Atf4 secondary Receptor Protein-Tyrosine Kinases Zinc Finger Protein GLI1 cytokine Antineoplastic Combined Chemotherapy Protocols tumor progression Capillary Permeability Myelogenous Leukemia-Chronic-BCR-ABL Positive biomarkers Transfection Lung Neoplasms Autoimmunity Neoplastic Stem Cells Herpesviridae Proteolysis Melanoma melanoma tumor Genetic Predisposition to Disease Vascular Endothelial Growth Factor A Molecular Targeted Therapy Immunotherapy Cell Communication Activating Transcription Factor 4 Programmed Cell Death 1 Receptor Gene Rearrangement T lymphocytes Tissue Engineering K562 Cells Breast Neoplasms Secreted Matrix Metalloproteinases Azacitidine administration & dosage
Last updated on Wednesday, February 05, 2020